The costs of Alzheimer's disease and the value of effective therapies.

Stefanacci RG. The costs of Alzheimer's disease and the value of effective therapies. Am J Manag Care. 2011 Nov; 17 Suppl 13:S356-62.

View in: PubMed

subject areas

Age Factors
Aging
Alzheimer Disease
Cholinesterase Inhibitors
Disease Progression
Galantamine
Health Care Costs
Health Expenditures
Humans
Indans
Medicare
Medicare Part D
Memantine
Piperidines
Psychometrics
United States

authors with profiles

Richard Stefanacci

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement